Diagnostic methods
Veterinary immunoassay vs molecular testing
Understand what qFLASH and mFIND measure, how their workflows differ, and what to check when building a veterinary test menu.

Veterinary immunoassay vs molecular testing is primarily a comparison of what a test measures. An immunoassay uses antigen–antibody binding to detect or measure a target such as a biomarker, antigen or antibody. Nucleic acid testing looks for a defined DNA or RNA target. The appropriate choice starts with the clinical question and the individual assay, rather than the instrument alone.
For a veterinary laboratory or distributor, this distinction helps explain where the qFLASH fluorescence immunoassay platform and the mFIND molecular testing platform fit within a test menu. They provide different types of information; a shared fluorescent readout does not make them the same technology.
What is the difference between the two methods?
In immunoassays, binding between an antigen and an antibody provides the recognition step. Depending on the test design, the measured target may be a biomarker, a pathogen antigen or an antibody produced by the animal. Cornell’s diagnostic laboratory describes antigen and antibody detection as central applications of veterinary serology and immunology. 1
In nucleic acid testing, the target is a selected genetic sequence. PCR is one way to amplify that target; isothermal amplification is another approach. The word molecular describes the testing category here, while PCR names a particular amplification method. Cornell’s PCR guidance likewise identifies DNA or RNA as the assay target. 2
Swipe horizontally to read the full table.
| What to compare | Fluorescence immunoassay | Nucleic acid testing |
|---|---|---|
| Recognition step | Antigen–antibody binding | Recognition and amplification of a defined nucleic acid target |
| Typical question | Is this antigen or antibody present, or what is the concentration of this biomarker? | Is the specified DNA or RNA target detected in this specimen? |
| Dawnsail platform in this guide | qFLASH | Veterinary mFIND |
| Consumable format | Assay-specific test strip or cartridge | Assay-specific microfluidic test chip |
| What a result means | Depends on the target, assay design and calibration | Depends on the target, specimen and assay interpretation rules |
| First document to check | The individual test’s instructions for use | The individual test’s instructions for use |
The table compares principles, not diagnostic accuracy. Neither technology is universally more suitable for every animal, target or specimen.
How does qFLASH fluorescence immunoassay work?
The current Dawnsail principle explanation describes a lateral-flow fluorescence workflow. After the prepared sample is added to the test strip, the target antigen binds to a labelled antibody. A capture antibody holds the resulting complex at the test line. The analyzer excites the fluorescent label, measures the signal and uses a calibration curve to calculate the antigen concentration. 3
That explanation describes the supplied sandwich-format antigen assay principle. It should not be treated as an identical reaction scheme for every item in the qFLASH menu. Other targets or assay formats can have different preparation and interpretation requirements.
The qFLASH biomarker test platform page groups the available tests by application and links to their instructions. For example, the supplied menu includes canine C-reactive protein (CRP) and symmetric dimethylarginine (SDMA). A buyer should confirm the intended species, specimen, units, measuring interval and compatible analyzer for each selected test.
The useful procurement question is therefore more specific than “How many tests are available?” Ask which documented assays match the laboratory’s intended work, and whether the training materials cover those exact assays.
How does mFIND nucleic acid testing work?
Dawnsail describes mFIND as microfluidic isothermal amplification nucleic acid detection. The current workflow has three main stages: prepare the sample using the specified buffers, load and seal the chip, and run amplification with fluorescence monitoring. The chip distributes the prepared sample into four reaction chambers. 4
The supplied principle text describes amplification at a constant 40°C and a 15-minute amplification stage. These figures describe that documented process. Collection, preparation, loading and result review add to the total time, and the individual assay instructions remain the operating reference.
The veterinary mFIND product page organizes the documented panels into areas such as feline and canine respiratory, digestive and blood-borne targets. Confirm the targets included in the selected chip and the permitted specimen before planning a panel workflow.
The sealed reaction format is intended to limit open handling during amplification. It does not remove the need for careful sample preparation, appropriate controls and the cleaning procedure specified for the system. It is also more precise to describe this platform as isothermal molecular testing than to call it a conventional thermal-cycling PCR analyzer.
Why can both systems use fluorescence?
Fluorescence is a way of reading a signal; it does not, by itself, identify the recognition chemistry. In the supplied qFLASH explanation, the fluorescent signal follows antigen–antibody binding on a test strip. In the supplied mFIND explanation, fluorescence is monitored during nucleic acid amplification in a chip.
When presenting either platform to a customer, describe three things separately: the target, the reaction and the reported result. This prevents a fluorescence reader, a fluorescence immunoassay and a molecular assay from being described as interchangeable simply because their instruments detect light.
What should a laboratory or distributor check?
Build a shortlist around the intended test menu, then review the operational requirements with the laboratory team. These six questions make the comparison more concrete.
- Which targets and species are required? List the actual assays needed. Separate biomarker measurement from pathogen antigen, antibody and nucleic acid detection, even when test names refer to the same disease area.
- Which specimens are accepted? Check the collection method, sample volume, preparation steps and storage conditions in each instructions-for-use document. Do not transfer a specimen rule from one platform to another.
- What does the complete workflow involve? Compare collection-to-report time, hands-on steps, preparation equipment, batch capacity and waste handling. An amplification time or reader time is only one part of that workflow.
- How are results and quality controls handled? Request the relevant calibration, control, invalid-result and repeat-testing instructions. Confirm what operators see and what they should do when a control fails.
- What evidence supports the particular assay? Ask for the evaluated species, specimen types, sample numbers, comparator and performance definitions. A platform specification or a correlation plot alone does not describe every assay’s clinical performance.
- What is needed for local implementation? Confirm the supplied documents, language, shelf life, storage, service arrangements and applicable local registration for the exact product configuration.
Keep the answers at assay level. A long platform menu is useful only when the required tests, instructions and operational support are available for the intended market.
Can the two platforms complement each other?
They can support different testing needs within the same laboratory, provided each assay is suitable for its intended use. A biomarker measurement and a nucleic acid result answer different questions, even when both contribute information to the same clinical assessment.
For that reason, this is not a universal “which is better?” ranking. Start with the required diagnostic information, then assess the assay and workflow that provide it. Clinical interpretation belongs with the veterinarian and the applicable instructions for use. As the ASPCA explains for PCR, detection of a pathogen’s nucleic acid does not, by itself, establish that it is causing the animal’s clinical signs or represents an active infection. 5
Common questions
Is mFIND the same as conventional PCR?
Both belong to nucleic acid testing, but they use different amplification approaches. The current mFIND materials describe constant-temperature amplification in a microfluidic chip. Conventional PCR uses repeated temperature cycles. Use the named method and assay instructions when discussing compatibility or performance.
Does a 15-minute assay mean a result in 15 minutes from collection?
No. The stated amplification or instrument time is not the same as collection-to-report time. Include specimen collection, preparation, chip loading and result review when estimating the full workflow.
Does one method always offer higher diagnostic accuracy?
No single ranking applies to every target and specimen. Review the validation evidence for the specific assay and intended use. Do not generalize a performance claim from one target to an entire platform.
Where can I find the relevant operating documents?
The Dawnsail resource library brings together platform materials and assay instructions. Use it alongside the qFLASH test menu and mFIND product information to identify the documents for your shortlist.
Sources and product documents
This guide is based on Dawnsail’s current product materials and its October 2026 principle explanations, with veterinary diagnostic references for general method definitions. External references explain the methods; they do not independently validate either Dawnsail platform.
- Cornell University — Serology & Immunology. Antigen and antibody testing in veterinary diagnostics.
- Cornell University — Interpretation of PCR results. Nucleic acid targets, controls and assay-specific reporting.
- Dawnsail — qFLASH principle and supporting materials. Sample preparation, lateral flow and fluorescent signal detection.
- Dawnsail — mFIND principle and supporting materials. Sample preparation, chip distribution and isothermal amplification.
- ASPCA — Common Veterinary Diagnostic Tests (PDF). Molecular testing and interpretation boundaries.
